News GMU selects three finalists for $250M Institute for Digital InnovAtion | Virginia Business George Mason University on Monday announced three development and property management firms as finalists to…Super UserJune 21, 2020
News AstraZeneca taps Catalent for COVID-19 vaccine finishing, packaging at Italian plant | FiercePharma British drugmaker AstraZeneca is shooting for the moon with its plan to produce 2 billion…Super UserJune 21, 2020
News University of Maryland Medical System awarded $18.7 million federal grant to fight coronavirus – Baltimore Sun The University of Maryland Medical System will receive more than $18.7 million in funding from…Super UserJune 21, 2020
News GSK gets FDA approval for HIV drug for children – MarketWatch Shares of GlaxoSmithKline GSK, +0.36% were down 0.05% in premarket trading on Monday after the…Super UserJune 21, 2020
News Novavax Appoints Biotechnology Veteran David Mott to Board of Directors | Novavax Inc. – IR Site GAITHERSBURG, Md., June 16, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology…Super UserJune 21, 2020
News Advisory Board | Johns Hopkins Technology Ventures The IDEA Board champions innovation and entrepreneurship across the Johns Hopkins University, providing the vision…Super UserJune 21, 2020
News ITI Enters into License Agreement with Ichor to Use Electroporation (EP) Delivery Technology in Phase I Study of DNA Vaccine Therapy, ITI-1001 – Immunomic Therapeutics ROCKVILLE, Md.–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of…Super UserJune 21, 2020
News Emmes Chosen as a Top Area Workplace ROCKVILLE, Md., June 17, 2020 /PRNewswire/ -- Emmes today announced that it was selected as one…Super UserJune 21, 2020
News GSK Expands Synthetic Lethality Scope With $120M Ideaya Bio Alliance – Xconomy GlaxoSmithKline got its first taste of synthetically lethal cancer therapies via an acquisition. Now it’s…Super UserJune 21, 2020
News Royalty Pharma, drug firm that doesn’t develop drugs, shatters IPO record Royalty Pharma, a business built on investing in other people’s medicines, raised $2.2 billion in…Super UserJune 21, 2020